David A. Siegel Kempharm, Inc Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.02 - $5.21 $138,287 - $179,224	-34,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.0 - $9.26 $2,000 - $3,704	-400 Reduced 1.15%	34,400 $173,000
Q4 2021 Feb 14, 2022	BUY	$7.6 - $10.26 $79,800 - $107,730	10,500 Added 43.21%	34,800 $303,000
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $211,896 - $323,433	24,300 New	24,300 $227,000
Q2 2021 Aug 16, 2021	SELL	$8.52 - $15.47 $91,164 - $165,529	-10,700 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$5.6 - $13.47 $59,919 - $144,129	10,700 New	10,700 $98,000

13.8M

68.1K

42K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.